$NUKK
Nukkleus Inc. Stock $nukk

$nukk Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000101376224002177 Filed on July 30, 2024

Income Statement

Concept	2024 Q3	2023 Q4	2022 Q4
Revenue		$5.242M	$0.00
YoY Change
Cost Of Revenue		$4.784M	$5.431M
YoY Change		-11.92%	-5.25%
Gross Profit		$458.7K	-$54.87K
YoY Change		-935.98%	-90.91%
Gross Profit Margin		8.75%
Selling, General & Admin			$1.015M
YoY Change			-20.36%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$592.9K
YoY Change			-34.99%
% of Gross Profit
Operating Expenses		$9.406M	$107.7K
YoY Change		8635.89%	-73.78%
Operating Profit		-$8.947M	-$162.5K
YoY Change		5404.63%	-83.97%
Interest Expense		$7.422K	$214.6K
YoY Change		-96.54%	-1066.85%
% of Operating Profit
Other Income/Expense, Net		$19.13K	$2.570K
YoY Change		644.51%	-310.66%
Pretax Income		-$8.928M	$107.0K
YoY Change		-8446.35%	-124.72%
Income Tax			$0.00
% Of Pretax Income			0.0%
Net Earnings		-$8.928M	$107.0K
YoY Change		-8446.27%	-124.72%
Net Earnings / Revenue		-170.3%
Basic Earnings Per Share		-$0.85	-$0.11
Diluted Earnings Per Share		-$0.85	$0.02
COMMON SHARES
Basic Shares Outstanding	14.80M shares	1.815M shares	2.076M shares
Diluted Shares Outstanding		10.56M shares	10.07M shares

Balance Sheet

Concept	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments		$6.111M
YoY Change		-87.18%
Cash & Equivalents	$204.1K	$6.111M
Short-Term Investments
Other Short-Term Assets	$32.93K	$740.00
YoY Change	4349.59%	-99.97%
Inventory
Prepaid Expenses
Receivables		$102.8K
Other Receivables	$29.49K	$0.00
Total Short-Term Assets	$1.960M	$6.112M
YoY Change	-67.93%	-87.18%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$391.2K	$6.602M
YoY Change	-94.07%	0.0%
Other Assets
YoY Change
Total Long-Term Assets	$421.5K	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$1.960M	$6.112M
Total Long-Term Assets	$421.5K	$0.00
Total Assets	$2.382M	$6.112M
YoY Change	-61.03%	-87.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$296.2K	$315.0K
YoY Change	-5.99%	1.75%
Accrued Expenses		$424.9K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt		$3.651M
YoY Change		124.62%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.62M	$3.966M
YoY Change	193.07%	104.96%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$10.64K
YoY Change		-94.1%
Total Long-Term Liabilities	$705.3K	$10.64K
YoY Change	6528.57%	-94.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.62M	$3.966M
Total Long-Term Liabilities	$705.3K	$10.64K
Total Liabilities	$12.33M	$3.976M
YoY Change	210.03%	87.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$44.94M	-$7.800M
YoY Change	476.14%	36.55%
Common Stock	$1.390K	$3.880M
YoY Change	-99.96%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$9.947M	-$3.920M
YoY Change
Total Liabilities & Shareholders Equity	$2.382M	$6.112M
YoY Change	-61.03%	-87.18%

Cashflow Statement

Concept	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	-$8.928M	$107.0K
YoY Change	-8446.27%	-124.72%
Depreciation, Depletion And Amortization		$592.9K
YoY Change		-34.99%
Cash From Operating Activities	-$738.0K	-$78.25K
YoY Change	843.13%	-64.82%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities	$130.1K	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$746.2K	-25.01M
YoY Change	-102.98%	-1910.57%
NET CHANGE
Cash From Operating Activities	-$738.0K	-78.25K
Cash From Investing Activities	$130.1K	0.000
Cash From Financing Activities	$746.2K	-25.01M
Net Change In Cash	$171.8K	-25.09M
YoY Change	-100.68%	11256.1%
FREE CASH FLOW
Cash From Operating Activities	-$738.0K	-$78.25K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10563645	shares
CY2022Q4	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q4	dei	Document Type DocumentType	10-Q
CY2023Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q4	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q4	dei	Entity File Number EntityFileNumber	001-39341
CY2023Q4	dei	Entity Registrant Name EntityRegistrantName	Nukkleus Inc.
CY2023Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3912845
CY2023Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	525 Washington Boulevard
CY2023Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	Jersey City
CY2023Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07310
CY2023Q4	dei	City Area Code CityAreaCode	212
CY2023Q4	dei	Local Phone Number LocalPhoneNumber	791-4663
CY2023Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q4	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q4	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q4	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14802414	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	204148	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19318	usd
CY2023Q4	nukk	Customer Custodial Cash Current CustomerCustodialCashCurrent	659462	usd
CY2023Q3	nukk	Customer Custodial Cash Current CustomerCustodialCashCurrent	672501	usd
CY2023Q4	nukk	Customer Digital Currency Assets Current CustomerDigitalCurrencyAssetsCurrent	996113	usd
CY2023Q4	nukk	Digital Assets Current DigitalAssetsCurrent	2945	usd
CY2023Q3	nukk	Digital Assets Current DigitalAssetsCurrent	1973	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	29491	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2039274	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	32927	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	32522	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1960086	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	2928408	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	391217	usd
CY2023Q3	us-gaap	Equity Method Investments EquityMethodInvestments	391217	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30271	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	421488	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	424217	usd
CY2023Q4	us-gaap	Assets Assets	2381574	usd
CY2023Q3	us-gaap	Assets Assets	3352625	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	296162	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	138666	usd
CY2023Q4	nukk	Customer Custodial Cash Liabilities Current CustomerCustodialCashLiabilitiesCurrent	1331330	usd
CY2023Q3	nukk	Customer Custodial Cash Liabilities Current CustomerCustodialCashLiabilitiesCurrent	1443011	usd
CY2023Q4	nukk	Customer Digital Currency Liabilities Current CustomerDigitalCurrencyLiabilitiesCurrent	996113	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	50000	usd
CY2023Q4	nukk	Accrued Payroll Liability And Directors Compensation Current AccruedPayrollLiabilityAndDirectorsCompensationCurrent	430858	usd
CY2023Q3	nukk	Accrued Payroll Liability And Directors Compensation Current AccruedPayrollLiabilityAndDirectorsCompensationCurrent	402241	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	169945	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	160926	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	169745	usd
CY2023Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	169872	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11622879	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9123465	usd
CY2023Q4	nukk	Interest Payable Related Parties Non Current InterestPayableRelatedPartiesNonCurrent	7280	usd
CY2023Q3	nukk	Interest Payable Related Parties Non Current InterestPayableRelatedPartiesNonCurrent	1771	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	705280	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	422390	usd
CY2023Q4	us-gaap	Liabilities Liabilities	12328159	usd
CY2023Q3	us-gaap	Liabilities Liabilities	9545855	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13899712	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13899712	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10074657	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10074657	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1390	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	1007	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35023820	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25543048	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44940441	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31769244	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-31354	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	31959	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-9946585	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-6193230	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2381574	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3352625	usd
CY2023Q4	us-gaap	Revenues Revenues	5242391	usd
CY2022Q4	us-gaap	Revenues Revenues	5376388	usd
CY2023Q4	us-gaap	Cost Of Revenue CostOfRevenue	4783691	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	5431261	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	458700	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	-54873	usd
CY2023Q4	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	21018	usd
CY2022Q4	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	49122	usd
CY2023Q4	us-gaap	Professional Fees ProfessionalFees	2862110	usd
CY2022Q4	us-gaap	Professional Fees ProfessionalFees	677103	usd
CY2023Q4	nukk	Compensation And Related Benefits CompensationAndRelatedBenefits	253836	usd
CY2022Q4	nukk	Compensation And Related Benefits CompensationAndRelatedBenefits	160260	usd
CY2023Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6145942	usd
CY2023Q4	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	123023	usd
CY2022Q4	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	195137	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	9405929	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	1081622	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-8947229	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1136495	usd
CY2023Q4	us-gaap	Interest Expense Other InterestExpenseOther	7422	usd
CY2023Q4	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	26556	usd
CY2022Q4	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2573	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	19134	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2573	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8928095	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1133922	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-8928095	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1133922	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-8928095	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1133922	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	63313	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	27983	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8991408	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1161905	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.85
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10563645	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10074657	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-6193230	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2015601	usd
CY2023Q4	nukk	Stock Issued During Period Value Conversion Of Related Party Debts Into Common Stock StockIssuedDuringPeriodValueConversionOfRelatedPartyDebtsIntoCommonStock	2997624	usd
CY2023Q4	nukk	Stock Issued During Period Value Issuance Of Common Stock In Connection With Reverse Recapitalization StockIssuedDuringPeriodValueIssuanceOfCommonStockInConnectionWithReverseRecapitalization	150161	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	74667	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-8928095	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-63313	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-9946585	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	10890580	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	146876	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1133922	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-27983	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9875551	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-8928095	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1133922	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3449	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	592892	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	2090268	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	146876	usd
CY2023Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6145942	usd
CY2023Q4	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	3906	usd
CY2022Q4	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-164	usd
CY2022Q4	nukk	Impairment Of Digital Assets ImpairmentOfDigitalAssets	7610	usd
CY2023Q4	nukk	Increase Decreasein Customer Digital Currency Assets IncreaseDecreaseinCustomerDigitalCurrencyAssets	970879	usd
CY2022Q4	nukk	Increase Decreasein Customer Digital Currency Assets IncreaseDecreaseinCustomerDigitalCurrencyAssets	60324	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1242	usd
CY2023Q4	nukk	Increase Decrease In Digital Assets IncreaseDecreaseInDigitalAssets	861	usd
CY2022Q4	nukk	Increase Decrease In Digital Assets IncreaseDecreaseInDigitalAssets	-9798	usd
CY2023Q4	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	4133506	usd
CY2022Q4	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	-284562	usd
CY2023Q4	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1980	usd
CY2022Q4	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	12731	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	147480	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-808	usd
CY2023Q4	nukk	Increase Decrease Customer Custodial Cash Liabilities IncreaseDecreaseCustomerCustodialCashLiabilities	-171568	usd
CY2022Q4	nukk	Increase Decrease Customer Custodial Cash Liabilities IncreaseDecreaseCustomerCustodialCashLiabilities	5874714	usd
CY2023Q4	nukk	Increase Decrease In Customer Digital Currency Liabilities IncreaseDecreaseInCustomerDigitalCurrencyLiabilities	970879	usd
CY2022Q4	nukk	Increase Decrease In Customer Digital Currency Liabilities IncreaseDecreaseInCustomerDigitalCurrencyLiabilities	60324	usd
CY2023Q4	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	4077839	usd
CY2022Q4	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	93254	usd
CY2023Q4	nukk	Increase Decrease In Accrued Payroll Liability And Directors Compensation IncreaseDecreaseInAccruedPayrollLiabilityAndDirectorsCompensation	26572	usd
CY2022Q4	nukk	Increase Decrease In Accrued Payroll Liability And Directors Compensation IncreaseDecreaseInAccruedPayrollLiabilityAndDirectorsCompensation	30000	usd
CY2023Q4	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	9011	usd
CY2022Q4	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-66627	usd
CY2023Q4	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	6015	usd
CY2023Q4	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-7209	usd
CY2022Q4	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	8538	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-737831	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5834320	usd
CY2022Q4	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	67800	usd
CY2023Q4	nukk	Proceeds From Note Receivable Related Parties ProceedsFromNoteReceivableRelatedParties	130137	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	130137	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-67800	usd
CY2023Q4	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	150161	usd
CY2023Q4	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	50000	usd
CY2023Q4	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	627967	usd
CY2023Q4	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	81957	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	746171	usd
CY2023Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33314	usd
CY2022Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	384202	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	171791	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6150722	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	691819	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2384417	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	863610	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8535139	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	204148	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	279728	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	659462	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	8255411	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	863610	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8535139	usd
CY2023Q4	us-gaap	Interest Paid Net InterestPaidNet	1407	usd
CY2023Q4	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	2997624	usd
CY2021Q4	us-gaap	Other Investments OtherInvestments	1000000	usd
CY2021Q4	nukk	Exchange Shares Percentage ExchangeSharesPercentage	0.04545	pure
CY2023Q4	us-gaap	Cash Cash	204000	usd
CY2023Q3	us-gaap	Cash Cash	19000	usd
CY2023Q4	nukk	Working Capital Deficits WorkingCapitalDeficits	9663000	usd
CY2023Q4	nukk	Shares Reflecting Exchange Ratio SharesReflectingExchangeRatio	36.44532
CY2023Q4	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="text-decoration:underline">Use of estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Changes in these estimates and assumptions may have a material impact on the condensed consolidated financial statements and accompanying notes. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Significant estimates during the three months ended December 31, 2023 and 2022 include the allowance for doubtful accounts, the assumptions used in assessing impairment of long-term assets, the valuation of deferred tax assets and associated valuation allowances, the valuation of stock-based compensation, and the fair value of customer digital currency assets and liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	204148	usd
CY2023Q4	nukk	Cash Percentage CashPercentage	1	pure
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19318	usd
CY2023	nukk	Cash Percentage CashPercentage	1	pure
CY2023Q4	nukk	Customer Digital Currency Assets Current CustomerDigitalCurrencyAssetsCurrent	996113	usd
CY2023Q4	nukk	Customer Digital Currency Liabilities Current CustomerDigitalCurrencyLiabilitiesCurrent	996113	usd
CY2023Q4	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Credit risk and uncertainties</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The ramifications of the outbreak of the novel strain of COVID-19, reported to have started in December 2019 and spread globally, are filled with uncertainty and changing quickly. Our operations have continued during the COVID-19 pandemic and we have not had significant disruption.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Company is operating in a rapidly changing environment so the extent to which COVID-19 impacts its business, operations and financial results from this point forward will depend on numerous evolving factors that the Company cannot accurately predict. Those factors include the following: the duration and scope of the pandemic; governmental, business and individuals’ actions that have been and continue to be taken in response to the pandemic.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Company maintains a portion of its cash in bank and financial institution deposits within U.S. that at times may exceed federally-insured limits of $250,000. The Company manages this credit risk by concentrating its cash balances, including customer custodial cash, in high quality financial institutions and by periodically evaluating the credit quality of the primary financial institutions holding such deposits. The Company may also hold cash at digital asset trading platforms and performs a regular assessment of these digital asset trading platforms as part of its risk management process. The Company has not experienced any losses in such bank accounts and believes it is not exposed to any risks on its cash in bank accounts. At December 31, 2023, </span>there were no balances in excess of the federally-insured limits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">We may maintain our cash assets at financial institutions in the U.S. in amounts that may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limit of $250,000. Actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. For example, in response to the rapidly declining financial condition of regional banks Silicon Valley Bank (“SVB”) and Signature Bank (“Signature”), the California Department of Financial Protection and Innovation and the New York State Department of Financial Services closed SVB and Signature on March 10, 2023 and March 12, 2023, respectively, and the FDIC was appointed as receiver for SVB and Signature. In the event of a failure or liquidity issues of or at any of the financial institutions where we maintain our deposits or other assets, we may incur a loss to the extent such loss exceeds the FDIC insurance limitation, which could have a material adverse effect upon our liquidity, financial condition and our results of operations. Similarly, if our customers experience liquidity issues as a result of financial institution defaults or non-performance where they hold cash assets, their ability to pay us may become impaired and could have a material adverse effect on our results of operations, including the collection of accounts receivable and cash flows.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of trade accounts receivable. A portion of the Company’s sales are credit sales which is to the customer whose ability to pay is dependent upon the industry economics prevailing in these areas; however, concentrations of credit risk with respect to trade accounts receivable is limited due to short-term payment terms. The Company also performs ongoing credit evaluations of its customers to help further reduce credit risk.</span></p>
CY2023Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	250000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	600000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	637072	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	32927	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	32522	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P3Y
CY2023Q4	nukk	Services Cost Percentage ServicesCostPercentage	0.02	pure
CY2023Q4	us-gaap	Revenues Revenues	5242391	usd
CY2022Q4	us-gaap	Revenues Revenues	5376388	usd
CY2023Q4	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	21018	usd
CY2022Q4	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	49122	usd
CY2023Q4	nukk	Foreign Currency Translation Description ForeignCurrencyTranslationDescription	Asset and liability accounts at December 31, 2023 and September 30, 2023 were translated at 0.7849 GBP and 0.8199 GBP to $1.00, respectively, which were the exchange rates on the balance sheet dates. Asset and liability accounts at December 31, 2023 and September 30, 2023 were translated at 0.9046 EUR and 0.9446 EUR to $1.00, respectively, which were the exchange rates on the balance sheet dates. Asset and liability accounts at December 31, 2023 and September 30, 2023 were translated at 1.3264 CAD and 1.3591 CAD to $1.00, which was the exchange rate on the balance sheet date. Equity accounts were stated at their historical rates. The average translation rate applied to the statement of operations for the three months ended December 31, 2023 and 2022 was 0.8053 GBP and 0.8525 GBP to $1.00, respectively. The average translation rate applied to the statement of operations for the three months ended December 31, 2023 and 2022 was 0.9288 EUR and 0.9806 EUR to $1.00. The average translation rate applied to the statement of operations for the three months ended December 31, 2023 was 1.3619 CAD to $1.00. Cash flows from the Company’s operations are calculated based upon the local currencies using the average translation rate.
CY2023Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6825286	shares
CY2022Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	167143	shares
CY2023Q4	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><span style="text-decoration:underline">Reclassification </span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications have no effect on the previously reported financial position, results of operations and cash flows.</p>
CY2023Q4	nukk	Shares Reflecting Exchange Ratio SharesReflectingExchangeRatio	36.44532
CY2023Q4	nukk	Customer Custodial Cash CustomerCustodialCash	659462	usd
CY2023Q3	nukk	Customer Custodial Cash CustomerCustodialCash	672501	usd
CY2023Q4	nukk	Customer Digital Currency Assets Current CustomerDigitalCurrencyAssetsCurrent	996113	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1655575	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	672501	usd
CY2023Q4	nukk	Customer Custodial Cash Liabilitie CustomerCustodialCashLiabilitie	1331330	usd
CY2023Q3	nukk	Customer Custodial Cash Liabilitie CustomerCustodialCashLiabilitie	1443011	usd
CY2023Q4	nukk	Customer Digital Currency Liabilities Current CustomerDigitalCurrencyLiabilitiesCurrent	996113	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2327443	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1443011	usd
CY2023Q4	nukk	Customer Digital Currency Assets Current CustomerDigitalCurrencyAssetsCurrent	996113	usd
CY2023Q4	nukk	Customer Digital Currency Assets Percentage CustomerDigitalCurrencyAssetsPercentage	1	pure
CY2023Q4	nukk	Digital Asset Gross DigitalAssetGross	2945	usd
CY2023Q4	nukk	Digital Assets1 DigitalAssets1	2945	usd
CY2023Q3	nukk	Digital Asset Gross DigitalAssetGross	1973	usd
CY2023Q3	nukk	Digital Assets1 DigitalAssets1	1973	usd
CY2022Q4	nukk	Impairment Of Digital Assets ImpairmentOfDigitalAssets	7610	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	50000	usd
CY2023Q4	nukk	Unearned Revenue UnearnedRevenue	158378	usd
CY2023Q3	nukk	Unearned Revenue UnearnedRevenue	151617	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11367	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	18255	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	169745	usd
CY2023Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	169872	usd
CY2023Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2015601	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	124286	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.53
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	124286	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.53
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	90000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	30.5
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	34286	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	5.25
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	34286	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	5.25
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	34286	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	5.25
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	29491	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2039274	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8178726	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6808749	usd
CY2023Q4	us-gaap	Interest Income Other InterestIncomeOther	2545	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	1980	usd
CY2023Q3	us-gaap	Line Of Credit LineOfCredit	127820	usd
CY2023Q4	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	127820	usd
CY2023Q4	us-gaap	Securities Borrowed SecuritiesBorrowed	4000	gbp
CY2023Q4	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	270000	usd
CY2023Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	563	usd
CY2023Q4	us-gaap	Interest Expense InterestExpense	7422	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	7280	usd
CY2023Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1771	usd
CY2023Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2022Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q4	us-gaap	Revenues Revenues	5242391	usd
CY2022Q4	us-gaap	Revenues Revenues	5376388	usd
CY2023Q4	us-gaap	Cost Of Revenue CostOfRevenue	4783691	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	5431261	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	458700	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	-54873	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	9405929	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	1081622	usd
CY2023Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	19134	usd
CY2022Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2573	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-8928095	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1133922	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3449	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	592892	usd
CY2023Q4	us-gaap	Assets Assets	2381574	usd
CY2022Q4	us-gaap	Assets Assets	3352625	usd
CY2023Q4	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.12	pure
CY2023Q4	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	0.25
CY2023Q4	nukk	Initial Closing Amount InitialClosingAmount	50000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	1	pure
CY2023Q4	srt	Short Term Debt Other Average Rate Paid ShortTermDebtOtherAverageRatePaid	0.30	pure
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	us-gaap	Loans Payable Current LoansPayableCurrent		usd
CY2022Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022Q4	us-gaap	Interest Expense Other InterestExpenseOther		usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.85
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10074657	shares
CY2022Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023Q4	nukk	Impairment Of Digital Assets ImpairmentOfDigitalAssets		usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2022Q4	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties		usd
CY2023Q4	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
CY2022Q4	nukk	Proceeds From Note Receivable Related Parties ProceedsFromNoteReceivableRelatedParties		usd
CY2022Q4	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
CY2022Q4	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt		usd
CY2022Q4	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022Q4	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q4	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-8928000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-738000	usd
CY2023Q3	nukk	Customer Digital Currency Assets Current CustomerDigitalCurrencyAssetsCurrent		usd
CY2023Q3	nukk	Customer Digital Currency Liabilities Current CustomerDigitalCurrencyLiabilitiesCurrent		usd
CY2023Q3	nukk	Customer Digital Currency Assets Current CustomerDigitalCurrencyAssetsCurrent		usd
CY2023Q3	nukk	Customer Digital Currency Assets Percentage CustomerDigitalCurrencyAssetsPercentage		pure
CY2023Q4	nukk	Digital Assets Impairment Charges DigitalAssetsImpairmentCharges		usd
CY2023Q3	nukk	Digital Assets Impairment Charges DigitalAssetsImpairmentCharges		usd
CY2023Q4	nukk	Impairment Of Digital Assets ImpairmentOfDigitalAssets		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares		shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
CY2023Q4	us-gaap	Line Of Credit LineOfCredit		usd
CY2023Q4	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001787518

Files In Submission

Name	View Source	Status
0001013762-24-002177-index-headers.html	Edgar Link	pending
0001013762-24-002177-index.html	Edgar Link	pending
0001013762-24-002177.txt	Edgar Link	pending
0001013762-24-002177-xbrl.zip	Edgar Link	pending
ea0210001-10q_nukkleus.htm	Edgar Link	pending
ea021000101ex31-1_nukkle.htm	Edgar Link	pending
ea021000101ex32-1_nukkle.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nukk-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
nukk-20231231_cal.xml	Edgar Link	unprocessable
nukk-20231231_def.xml	Edgar Link	unprocessable
nukk-20231231_lab.xml	Edgar Link	unprocessable
nukk-20231231_pre.xml	Edgar Link	unprocessable
ea0210001-10q_nukkleus_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NUKK
Nukkleus Inc. Stock $nukk

2024 Q3 Form 10-Q Financial Statement

#000101376224002177 Filed on July 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NUKK Nukkleus Inc. Stock $nukk

2024 Q3 Form 10-Q Financial Statement

#000101376224002177 Filed on July 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NUKK
Nukkleus Inc. Stock $nukk